Clinical trial · Interventional
Preventive Effect of Boron-based Gel on Radiation Dermatitis
Preventive Effect of Boron-based Gel on Radiation Dermatitis in Patients With Breast Cancer: Phase III Randomized, Double-blind, Placebo-controlled Clinical Trial
NCT04239560CI-TRIAL-00043042boron_gelcompletedPhase 3ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Preventive Effect of Boron-based Gel on Radiation Dermatitis
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Radiodermatitis | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Boron-based Gel (Fibore) | Drug | — | UNRESOLVED |
| Placebos | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Boron-based Gel
- description
- During each radiation therapy session, 15 minutes before radiotherapy, 3% sodium pentahydrate panteurate will be used.
- interventionNames
- Drug: Boron-based Gel (Fibore)
- type
- PLACEBO_COMPARATOR
- label
- Radiation Traumatic Dermatitis Treated with Placebo
- description
- During each radiotherapy session, 15 minutes before radiotherapy, the gel will be free of any chemical treatments
- interventionNames
- Drug: Placebos
Primary outcomes (1)
- measure
- Radiation Therapy Oncology Group (RTOG) criteria
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Patients who are admitted to the study are enrolled in the study and have head and neck cancer in the breast, and are between the ages of 18 and 75 years old and have not received radiotherapy before. Exclusion Criteria: * Pregnant women, patients with unknown dermatitis and those without any willing to participate in this study were excluded.
References
Publications (0)
Data not yet available
No reference posted for this study.